RUA Life Sciences plc (RUA.L)

GBp 11.0

(0.0%)

Market Cap (In GBp)

6.82 Million

Revenue (In GBp)

2.19 Million

Net Income (In GBp)

-1.44 Million

Avg. Volume

253.79 Thousand

Currency
GBp
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
8.5-15.7
PE
-
EPS
-
Beta Value
1.123
ISIN
GB0033360586
CUSIP
G0402P119
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. William Donald Brown
Employee Count
-
Website
https://rualifesciences.com
Ipo Date
1997-02-26
Details
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.